Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Mallinckrodt
Express Scripts
Johnson and Johnson
Harvard Business School

Last Updated: December 16, 2019

DrugPatentWatch Database Preview

Cephazone Pharma Company Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the competitive landscape for CEPHAZONE PHARMA, and what generic and branded alternatives to CEPHAZONE PHARMA drugs are available?

CEPHAZONE PHARMA has five approved drugs.



Summary for Cephazone Pharma
US Patents:0
Tradenames:3
Ingredients:3
NDAs:5

Drugs and US Patents for Cephazone Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-001 Mar 26, 2007 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-002 Mar 26, 2007 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-004 Mar 26, 2007 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065294-003 Mar 26, 2007 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065348-001 Jan 25, 2010 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065295-001 Mar 18, 2009 DISCN No No   Start Trial   Start Trial
Cephazone Pharma CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 065296-001 Mar 18, 2009 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Baxter
AstraZeneca
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.